Our team at Millendo is relentlessly pursuing therapies that alleviate patient suffering due to orphan endocrine diseases
Join Our Team
Discover how “Millendoers”
are making things happen and how you can join us
Millendo in the News
December 4, 2019
Millendo Therapeutics Announces Pricing of Public Offering of Common Stock
November 13, 2019
Millendo Therapeutics Reports Third Quarter 2019 Operating and Financial
Results
